Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus
Conclusions: CANA prevents intrarenal AGT upregulation and oxidative stress and which may mitigate high blood pressure, renal tubular fibrosis, and renal inflammation in T2DM.Am J Nephrol 2019;49:331 –341
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Canagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diets | Eating Disorders & Weight Management | Endocrinology | High Fat | Hypertension | Invokana | Neurology | New Zealand Health | Nutrition | Obesity | SGLT2 Inhibitors | Sodium | Urology & Nephrology